Analytics for biologics and vaccines .: NR16-185/2017E-PDF
“Biologics and vaccine developers leverage our analytics expertise to advance their innovative treatments from discovery to application for clinical trials. We also transfer our data and methods to Contract Research Organizations (CROs) and Contract Manufacturing Organizations (CMOs), enabling them to offer new services while strengthening the Canadian biopharma ecosystem”--P. [1].
Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.848041&sl=0
| Department/Agency | National Research Council Canada. |
|---|---|
| Title | Analytics for biologics and vaccines . |
| Publication type | Monograph |
| Language | [English] |
| Other language editions | [French] |
| Format | Electronic |
| Electronic document | |
| Note(s) | Issued also in French under title: Analytique pour produits biologiques et vaccins. Caption title. "January 2018." Issued also in print format. |
| Publishing information | [Ottawa] : National Research Council Canada, 2018. |
| Description | [2] p. : col. ill. |
| ISBN | 9780660240534 |
| Catalogue number |
|
| Subject terms | Pharmaceutical biotechnology |
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.- Date modified: